Dr. Smiddy works in the Vaccine Analytical Research & Development department at Merck & Co., Inc., Rahway, NJ, USA on the High Throughput Analytics team supporting vaccine process and formulation development through assay development and automation. Specifically, her work focuses on the development and automation of cell imaging- and flow cytometry-based assays for characterizing potency, antibody neutralization, and protein expression. Before joining Merck in 2020, Dr. Smiddy received a BS in Chemistry from Bradley University and a PhD in Analytical Chemistry from UNC-Chapel Hill. Her PhD work was completed in Dr. Nancy Albritton’s lab where she developed microfabricated devices and automated imaging pipelines for high-throughput single-cell and clonal colony sorting applications.
Dr. Smiddy works in the Vaccine Analytical Research & Development department at Merck & Co., Inc., Rahway, NJ, USA on the High Throughput Analytics team supporting vaccine process and formulation development through assay development and automation. Specifically, her work focuses on the development and automation of cell imaging- and flow cytometry-based assays for characterizing potency, antibody neutralization, and protein expression. Before joining Merck in 2020, Dr. Smiddy received a BS in Chemistry from Bradley University and a PhD in Analytical Chemistry from UNC-Chapel Hill. Her PhD work was completed in Dr. Nancy Albritton’s lab where she developed microfabricated devices and automated imaging pipelines for high-throughput single-cell and clonal colony sorting applications.